Boston Scientific Corporation (BSX)

NYSE: BSX · IEX Real-Time Price · USD
-0.73 (-1.38%)
At close: Sep 27, 2023, 4:00 PM
+0.32 (0.61%)
After-hours: Sep 27, 2023, 7:16 PM EDT
Market Cap 76.29B
Revenue (ttm) 13.40B
Net Income (ttm) 861.00M
Shares Out 1.46B
EPS (ttm) 0.60
PE Ratio 86.83
Forward PE 24.69
Dividend n/a
Ex-Dividend Date n/a
Volume 8,360,766
Open 52.78
Previous Close 52.83
Day's Range 51.54 - 53.16
52-Week Range 38.22 - 55.38
Beta 0.78
Analysts Strong Buy
Price Target 60.43 (+15.99%)
Earnings Date Oct 26, 2023

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management s... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date May 18, 1992
Employees 45,000
Stock Exchange NYSE
Ticker Symbol BSX
Full Company Profile

Financial Performance

In 2022, BSX's revenue was $12.68 billion, an increase of 6.68% compared to the previous year's $11.89 billion. Earnings were $642.00 million, a decrease of -34.82%.

Financial Statements

Analyst Forecast

According to 21 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is $60.43, which is an increase of 15.99% from the latest price.

Price Target
(15.99% upside)
Analyst Consensus: Strong Buy
Stock Forecasts


CVS Health appoints Michael F. Mahoney to its Board of Directors

WOONSOCKET, R.I. , Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) has appointed Michael F.

Other symbols: CVS
7 days ago - PRNewsWire

6 Growth Stocks That Look Recession-Resistant, According to Morgan Stanley

Apple, Boston Scientific, Costco, Monster Beverage, UnitedHealth, and Colgate-Palmolive shares could still rise in the face of a consumer-spending slump, says Morgan Stanley.

8 days ago - Barrons

Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments

Boston Scientific Corp. BSX, +0.19% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company that has developed a treatment for a form of ch...

9 days ago - Market Watch

Boston Scientific to pay $850 mln upfront to buy Relievant Medsystems

Boston Scientific said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million.

9 days ago - Reuters

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass. , Sept. 19, 2023 /PRNewswire/ -- Boston Scien...

9 days ago - PRNewsWire

Investors should stick to the ‘late cycle playbook' and buy these sectors, says Morgan Stanley's Mike Wilson

Investors stumped as to where the U.S. economy is situated in the current business cycle, should be focusing on late-cycle stock sectors, which includes one that has been heating up of late.

9 days ago - Market Watch

Is Boston Scientific A Better Pick Over Altria Stock?

We believe that Boston Scientific stock (NYSE: BSX) is a better pick over Altria stock (NYSE: MO), given its better prospects.

Other symbols: MO
14 days ago - Forbes

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass. , Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporatio...

21 days ago - PRNewsWire

Boston Scientific Announces 2023 Investor Day Meeting and Conference Call Discussing Third Quarter 2023 Results

MARLBOROUGH, Mass. , Sept. 5, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategi...

22 days ago - PRNewsWire

Boston Scientific Reports Positive Results from Atrial Fibrillation Device

Boston Scientific (BSX) was the best-performing stock in the S&P 500 after the medical device maker reported positive results from a clinical trial for its system to treat patients with atrial fibrill...

4 weeks ago - Investopedia

ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints

Noninferiority established through high treatment success, low adverse event rates Findings presented at ESC Congress 2023 and simultaneously published in The New England Journal of Medicine MARLBOROU...

4 weeks ago - PRNewsWire

Which Is A Better Buy – Boston Scientific Stock Or Abbott?

Sharpe is a measure of return per unit of risk, and high-performance portfolios can provide the best of both worlds.

Other symbols: ABT
4 weeks ago - Forbes

Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System

First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systems MARLBOROUGH, Mass. , Aug. 8, 2023 /PRNewswire/ -- Boston Scientific ...

7 weeks ago - PRNewsWire

Stocks This Week: Hold Netflix And Sell Short Boston Scientific

Over the near term, the indices are likely to move higher into the 14th. The autumn correction will not be hard on many stocks such as Netflix.

Other symbols: NFLX
7 weeks ago - Forbes

Boston Scientific lifts annual profit forecast on heart devices strength

Boston Scientific raised its annual profit forecast for a second straight quarter on Thursday, banking on resilient demand for its cardiovascular devices as surgical procedure volumes pick up pace.

2 months ago - Reuters

Boston Scientific stock gets a boost from profit and sales beats, raised outloook

Shares of Boston Scientific Corp. BSX, -0.02% rallied 1.9% in premarket trading Thursday, after the medical technology company beat expectations for both profit and sales, amid strength in its cardiov...

2 months ago - Market Watch


MARLBOROUGH, Mass. , July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported...

2 months ago - PRNewsWire

Boston Scientific Announces Conference Call Discussing Second Quarter 2023 Results

MARLBOROUGH, Mass. , June 28, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarte...

3 months ago - PRNewsWire

Boston Scientific Elects Dr. Jessica L. Mega and Susan E.

MARLBOROUGH, Mass. , June 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Jessica L.

3 months ago - PRNewsWire

Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but...

3 months ago - MarketBeat

What's Next For Boston Scientific Stock After Outperforming During The 2022 Inflation Shock?

The notable rise in Boston Scientific's revenues in the recent past has also contributed to the stock's outperformance.

3 months ago - Forbes

Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock

MARLBOROUGH, Mass. , May 30, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today that its Series A 5.50% Mandatory Convertible Preferred Stock (the preferred stock) will aut...

4 months ago - PRNewsWire

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE™ Pulsed Field Ablation System* Results from global trial of the POLARx™ Cryoablation...

4 months ago - PRNewsWire

Shockwave Medical, Fast Grower, In Boston Scientific's Sights?

Shockwave Medical Inc. NASDAQ: SWAV, the largest component within the iShares Russell 2000 ETF NYSEARCA: IWM, briefly cleared a cup-with-handle buy point on May 12, but reversed lower along with the b...

Other symbols: SWAV
4 months ago - MarketBeat

Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference

MARLBOROUGH, Mass. , May 15, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023.

4 months ago - PRNewsWire